Chinese business practices; nonexistent US response.

In 2004, the last penicillin fermentation plant in the U.S. ceased operations. China had invested heavily in large-scale penicillin fermentation factories, and its domestic companies flooded the global market with products. They undercut U.S. and other western producers on price, driving them out of business. After China gained a stronghold in the U.S. and world market, its companies raised prices.

"Made in China: How U.S. Dependence on Chinese Medicines and Components Could Pose a Security Threat." By By Rosemary Gibson, Military Officers Association of America, 1/25/19.